# Cold Sore Fever Blister Treatment

NDC: 55910-963
Generic name: Docosanol
Labeler / Manufacturer: Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20220915
Marketing ended: 20270215
FDA application: ANDA208754

## Active ingredients

- DOCOSANOL: 100 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55910-963"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55910-963
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4286c19b-8c81-40f6-8d97-cfebba87c174